Print Page  Close Window
Fortune Small Business Ranks Meridian Bioscience Among America's Fastest-Growing Small Companies

CINCINNATI--(BUSINESS WIRE)--June 20, 2005--(NASDAQ:VIVO) - FORTUNE Small Business announced today that Meridian Bioscience, Inc., has been ranked 80 on the fifth annual FSB 100 list of the 100 fastest growing small companies in America. The list, which is comprised of public companies, appears in the July/August issue of FORTUNE Small Business, available on newsstands July 4 and at www.fsb.com.

John A. Kraeutler, President and Chief Operating Officer, stated, "This recognition by FORTUNE Small Business is a strong endorsement of Meridian's commitment to improve healthcare through superior tests for faster diagnosis of disease and life science technologies for the development and manufacturer of diagnostics and biopharmaceuticals."

To compile the list, FORTUNE Small Business asked financial research firm Zacks to screen annual reports for public companies with annual revenue of less than $200 million and a stock price of more than $1. Within that group, companies were ranked based on the past three years' earnings growth, revenue growth, and stock performance. Real estate firms and banks, which had begun to override the list in recent years, were not considered for the list this year.

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, and respiratory infections. Meridian diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals along with proteins and other biologicals used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices and diagnostics manufacturers in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.


    CONTACT: Meridian Bioscience, Inc.
             John A. Kraeutler, 513-271-3700

    SOURCE: Meridian Bioscience, Inc.